Related Experiment Video
Updated: Apr 20, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum
R A Zanette1, F P K Jesus2, M B Pilotto3
1Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), Campus UFSM, Prédio 20, Sala 4139, 97105-900, Santa Maria, RS, Brazil.
Abstract:
This study evaluated the in vitro and in vivo activity of micafungin alone and in combination with the iron chelator deferasirox against Pythium insidiosum. Micafungin showed a poor in vitro activity when it was used alone, but synergistic interactions were observed for 88.2% of the strains when the drug was combined with deferasirox. Smaller lesions were observed in infected rabbits receiving the combination therapy, although it favored disease dissemination to the lungs. The present results show that micafungin alone is ineffective against P. insidiosum, and the combination micafungin-deferasirox might have deleterious effects for the host.
Insights
Micafungin alone is ineffective against Pythium insidiosum. Combining micafungin with deferasirox showed synergy in vitro but led to lung dissemination in vivo, suggesting potential harm.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Pythium insidiosum is a fungus-like organism causing severe infections.
- Antifungal treatments often have limited efficacy.
- Iron availability can influence fungal growth and virulence.
Purpose of the Study:
- To evaluate the efficacy of micafungin, an antifungal drug, against Pythium insidiosum.
- To investigate the potential synergistic effect of combining micafungin with deferasirox, an iron chelator.
- To assess the in vitro and in vivo activity of this combination therapy.
Main Methods:
- In vitro susceptibility testing of micafungin and deferasirox against Pythium insidiosum strains.
- In vivo efficacy study using a rabbit infection model.
- Evaluation of lesion size and disease dissemination in infected rabbits.
Main Results:
- Micafungin alone demonstrated poor in vitro activity against Pythium insidiosum.
- A synergistic interaction between micafungin and deferasirox was observed in 88.2% of tested strains.
- Combination therapy resulted in smaller lesions but promoted lung dissemination in vivo.
Conclusions:
- Micafungin monotherapy is ineffective for treating Pythium insidiosum infections.
- The combination of micafungin and deferasirox may have adverse effects, promoting disease spread.
- Further research is needed to understand the complex interactions and host responses to this combination therapy.
More Related Videos
08:39Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins
Published on: December 24, 2017
10:01Quantification of Fungal Colonization, Sporogenesis, and Production of Mycotoxins Using Kernel Bioassays
Published on: April 23, 2012
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
Fungal Phylum Microsporidia
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Fungal Group Zygomycota